MLchartDataset catalogue

broad-spectrum human papillomavirus vaccine V505

Term · Oncology and biomedicine · MLC-T-ONC-012125

A non-infectious recombinant cancer vaccine prepared from the human papillomavirus (HPV) with potential immunoprophylactic activity. Vaccination with broad-spectrum human papillomavirus vaccine V505 may stimulate the host immune system to mount humoral and cytotoxic T lymphocyte (CTL) responses against HPV-infected cells. HPV infection, the cause of genital warts, is a risk factor for the development of cancers of the cervix, vagina, vulva, anus, and penis.

Table 1. Record
IdentifierMLC-T-ONC-012125
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012125",
  "term": "broad-spectrum human papillomavirus vaccine V505",
  "field": "Oncology and biomedicine",
  "definition": "A non-infectious recombinant cancer vaccine prepared from the human papillomavirus (HPV) with potential immunoprophylactic activity. Vaccination with broad-spectrum human papillomavirus vaccine V505 may stimulate the host immune system to mount humoral and cytotoxic T lymphocyte (CTL) responses against HPV-infected cells. HPV infection, the cause of genital warts, is a risk factor for the development of cancers of the cervix, vagina, vulva, anus, and penis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/broad-spectrum-human-papillomavirus-vaccine-v505/"
}

Record 3,873 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.